J&J Settles Illegal Marketing Claims Involving Risperdal
In a recent regulatory filing, Johnson & Johnson revealed that it had reached an “agreement in principle” with the federal Department of Justice and a number of states involving marketing practices for Risperdal. Specifically, drug maker Johnson & Johnson reported that it had reached a settlement of three pending False Claims Act cases pending in Pennsylvania, California, and Massachusetts related to marketing of Risperdal, Invega, and Natrecor. The drug maker also reported that it had reached a tentative settlement agreement with 38 states and the District of Columbia to settle non-Medicaid actions in connection with the sales and marketing of Risperdal and Invega. Recent reports have suggested that Johnson & Johnson and the Department of Justice have agreed to a settlement for up to $2.2 billion which will resolve federal probes into the company’s drug marketing practices. The settlement amount purportedly includes a $400 million criminal fine for the illegal promotion of Risperdal.Share This
The law firm you choose makes a difference. If you are the victim of an accident or an illness that someone else caused, the North Carolina personal injury law firm of Martin & Jones has the depth of experience, skills and sensitivity to make your road to recovery as smooth as possible. Whether you have experience with the legal system or have never hired a medical malpractice or personal injury lawyer before, our attorneys and staff will do our best to answer your questions, provide clear advice and prepare you and your family for what to expect. If you would like more information or to meet with one of our attorneys, please fill out the form below or call us at 800.662.1234.